| | |
Per share
|
| |
Total
|
| ||||||
Public offering price
|
| | | $ | 1.30 | | | | | $ | 8,060,000 | | |
Underwriting discount(1)
|
| | | $ | 0.078 | | | | | $ | 483,600 | | |
Proceeds to CAS Medical Systems, Inc., before expenses
|
| | | $ | 1.222 | | | | | $ | 7,576,400 | | |
| | |
Page
|
| |||
| | | | S-1 | | | |
| | | | S-2 | | | |
| | | | S-5 | | | |
| | | | S-13 | | | |
| | | | S-14 | | | |
| | | | S-15 | | | |
| | | | S-16 | | | |
| | | | S-17 | | | |
| | | | S-19 | | | |
| | | | S-19 | | | |
| | | | S-19 | | | |
| | | | S-19 | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 4 | | | |
| | | | 5 | | | |
| | | | 6 | | | |
| | | | 11 | | | |
| | | | 13 | | | |
| | | | 14 | | | |
| | | | 17 | | | |
| | | | 19 | | | |
| | | | 19 | | | |
| | | | 19 | | | |
| | | | 19 | | |
|
Offering price per share
|
| | | | | | | | | $ | 1.30 | | |
|
Net tangible book value per share of common stock, as of September 30, 2014, assuming all shares of preferred stock have been converted to common stock
|
| | | $ | 0.147 | | | |
|
| |||
|
As adjusted increase in net tangible book value per share of common stock, assuming
all shares of preferred stock have been converted to common stock, attributable to new investors |
| | | $ | 0.192 | | | | | | | | |
|
As adjusted net tangible book value per share of common stock, after offering, assuming
all shares of preferred stock have been converted to common stock |
| | | $ | 0.339 | | | | | | | | |
|
Dilution per share to new investors in the offering
|
| | | | | | | | | $ | 0.961 | | |
| | |
High
|
| |
Low
|
| ||||||
Fiscal Year 2015 | | | | | | | | | | | | | |
First Quarter (through February 10, 2015)
|
| | | $ | 1.92 | | | | | $ | 1.25 | | |
Fiscal Year 2014 | | | | | | | | | | | | | |
Fourth Quarter
|
| | | $ | 1.98 | | | | | $ | 1.50 | | |
Third Quarter
|
| | | $ | 2.06 | | | | | $ | 1.37 | | |
Second Quarter
|
| | | $ | 2.33 | | | | | $ | 1.80 | | |
First Quarter
|
| | | $ | 2.50 | | | | | $ | 1.65 | | |
Fiscal Year 2013 | | | | | | | | | | | | | |
Fourth Quarter
|
| | | $ | 2.00 | | | | | $ | 1.21 | | |
Third Quarter
|
| | | $ | 1.65 | | | | | $ | 1.29 | | |
Second Quarter
|
| | | $ | 2.37 | | | | | $ | 1.58 | | |
First Quarter
|
| | | $ | 2.38 | | | | | $ | 1.79 | | |
Fiscal Year 2012 | | | | | | | | | | | | | |
Fourth Quarter
|
| | | $ | 2.29 | | | | | $ | 1.66 | | |
Third Quarter
|
| | | $ | 2.25 | | | | | $ | 1.65 | | |
Second Quarter
|
| | | $ | 2.75 | | | | | $ | 1.60 | | |
First Quarter
|
| | | $ | 2.98 | | | | | $ | 1.62 | | |
Underwriter
|
| |
Number of
Shares |
| |||
Craig-Hallum Capital Group LLC
|
| | | | 6,200,000 | | |
| | | | | | | | |
Total
|
| |||||||||
| | |
Per Share
|
| |
Without
Overallotment |
| |
With Overallotment
|
| |||||||||
Public offering price
|
| | | $ | 1.30 | | | | | $ | 8,060,000 | | | | | $ | 9,269,000 | | |
Underwriting discount
|
| | | $ | 0.078 | | | | | $ | 483,600 | | | | | $ | 556,140 | | |
Proceeds, before expenses, to us
|
| | | $ | 1.222 | | | | | $ | 7,576,400 | | | | | $ | 8,712,860 | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 4 | | | |
| | | | 5 | | | |
| | | | 6 | | | |
| | | | 11 | | | |
| | | | 13 | | | |
| | | | 14 | | | |
| | | | 17 | | | |
| | | | 19 | | | |
| | | | 19 | | | |
| | | | 19 | | | |
| | | | 19 | | |